Risk for non-smoking-related cancer in atherosclerotic patients

Citation
L. Dreyer et Jh. Olsen, Risk for non-smoking-related cancer in atherosclerotic patients, CANC EPID B, 8(10), 1999, pp. 915-918
Citations number
36
Categorie Soggetti
Oncology,"Onconogenesis & Cancer Research
Journal title
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
ISSN journal
10559965 → ACNP
Volume
8
Issue
10
Year of publication
1999
Pages
915 - 918
Database
ISI
SICI code
1055-9965(199910)8:10<915:RFNCIA>2.0.ZU;2-S
Abstract
Some studies have suggested that the pathogenesis of atherosclerosis and th at of cancer have common features, and in addition to tobacco smoking, oxid ative stress, diet, and sex hormones have been considered as common etiolog ical factors. To investigate whether there is an association between athero sclerosis and cancer, we evaluated the cancer pattern of patients,vith athe rosclerosis of the aorta and of peripheral and cerebral vessels. A total of 69,485 patients with atherosclerosis were identified through the Danish Na tional Registry of Patients between 1977 and 1989, and the incidence of can cer in this group was calculated by linkage to the Danish Cancer Registry f or the period 1977-1993, No consistent excesses over the expected figures w ere seen for cancer at any site unrelated to tobacco smoking in either the total cohort or in subgroups. Specifically, we found no association at the individual level between atherosclerosis and colorectal cancers or hormone- related cancers, except from a decreased standardized incidence ratio of 0. 7 (95% confidence interval, 0.5-0.9) for endometrial cancer. The standardiz ed incidence ratio for cancers of the brain and nervous system was 1.1 (95% confidence interval, 0.9-1.3) for all patients combined, whereas patients with atherosclerosis of precerebral or cerebral arteries had a slightly inc reased risk (40%) for cancers of the brain and nervous system. The excess w as seen only during the initial 3 years after discharge from hospital, and the likely explanation was a missed diagnosis. The study does not support t he view that patients with atherosclerotic diseases represent a high-risk g roup for prostate cancer and potential future targets for prostate cancer s creening interventions.